Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|July 18, 2022
In vivo translational assessment of the GES genotype on the killing profile of ceftazidime, ceftazidime/avibactam and meropenem against Pseudomonas aeruginosaChristian M Gill, Antonio Oliver, Pablo Arturo Fraile-Ribot, et al.
Hospital Pharmacy|October 13, 2025
Assessment of Meropenem Stability in Meropenem Admixtures Using 2 g Vials and Normal Saline Prepared Using addEASE® ConnectorsChristian M Gill, Teresa Sierra, Nicholas Kovarik, et al.
Case Reports in Infectious Diseases|February 14, 2025
Carbapenem-Resistant Klebsiella pneumoniae Isolated From a Patient in a Midwestern U.S. Hospital With a History of Indian Travel: Therapeutic Strategies and Clinical OutcomesChristopher Phan, Kristen Tsai, Christian M Gill, et al.
Open Forum Infectious Diseases|July 12, 2021
Cefiderocol Pharmacokinetics in a Patient Receiving Continuous Venovenous HemodiafiltrationEmir Kobic, Christian M Gill, A Brian Mochon, et al.
The Journal of Antimicrobial Chemotherapy|July 31, 2023
Cefepime in vivo activity against carbapenem-resistant Enterobacterales that test as cefepime susceptible or susceptible-dose dependent in vitro: implications for clinical microbiology laboratory and cliniciansAliaa Fouad, Christian M Gill, Patricia J Simner, et al.
Emerging Microbes & Infections|February 14, 2023
Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosaChristian M Gill, Poonam Rajkotia, Amity L Roberts, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 31, 2020
Treatment and outcomes of Enterococcus faecium bloodstream infections in solid organ transplant recipientsNicholas J Mercuro, Christian M Gill, Rachel M Kenney, et al.
The Journal of Antimicrobial Chemotherapy|February 23, 2022
Omadacycline pharmacokinetics and soft-tissue penetration in diabetic patients with wound infections and healthy volunteers using in vivo microdialysisChristian M Gill, Andrew J Fratoni, Ashley K Shepard, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2023
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumanniiChristian M Gill, Debora Santini, Miki Takemura, et al.
The Journal of Antimicrobial Chemotherapy|April 2, 2024
Assessing the impact of meropenem exposure on ceftolozane/tazobactam-resistance development in Pseudomonas aeruginosa using in vitro serial passageAliaa Fouad, Samantha E Nicolau, Pranita D Tamma, et al.
Pageof 6